Clinical Trial

Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.

Recruiting
View on ClinicalTrials.gov →
Summary
The project aims to collect blood, tissue samples, and clinical data from patients with primary liver cancer (mainly hepatocellular carcinoma and intrahepatic cholangiocarcinoma) undergoing systemic therapy, surgical resection, or liver biopsy. Primary liver cancer is a growing global health challenge, with over one million cases expected by 2025 and a lack of effective treatments. The three-year study will systematically collect and store samples to support translational research for new therapies. Blood will be drawn at key points during systemic therapy, while tissue samples will be obtained from surgical resections or biopsies, provided they are not needed for diagnostics.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-21.
Trial Details
NCT Number NCT06899854
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Enrollment 53 participants
Start Date 2023-06-19
Primary Completion 2025-03-19 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-03